Zika Virus Vaccine: Progress and Challenges

Chao Shan, Xuping Xie, Pei-Yong Shi

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

The explosive emergence of Zika virus has inspired a global effort to develop vaccines. Zika virus, which is a flavivirus primarily transmitted by mosquitoes, can cause devastating congenital syndrome in fetuses of pregnant women, including microcephaly, craniofacial disproportion, spasticity, ocular abnormalities, and miscarriage. In adults, Zika infection has been linked to the autoimmune disorder Guillain-Barré syndrome. Thus, despite the current waning in newly reported Zika infections, an efficacious vaccine is urgently needed to help limit the emergence of another detrimental epidemic. Here we summarize the current status of the Zika vaccine pipeline and highlight the challenges for clinical efficacy trials. Shan et al. review the current status of the Zika virus vaccine pipeline, highlight the challenges for efficacy trial in humans, underline the knowledge gaps required for clinical development, and provide potential solutions to overcome the barriers toward licensure.

Original languageEnglish (US)
JournalCell Host and Microbe
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Vaccines
Eye Abnormalities
Flavivirus
Microcephaly
Spontaneous Abortion
Licensure
Infection
Culicidae
Pregnant Women
Fetus
Clinical Trials
Zika Virus

ASJC Scopus subject areas

  • Parasitology
  • Microbiology
  • Virology

Cite this

Zika Virus Vaccine : Progress and Challenges. / Shan, Chao; Xie, Xuping; Shi, Pei-Yong.

In: Cell Host and Microbe, 01.01.2018.

Research output: Contribution to journalArticle

@article{23010ea9739c47cc8677a168fa5a4bb4,
title = "Zika Virus Vaccine: Progress and Challenges",
abstract = "The explosive emergence of Zika virus has inspired a global effort to develop vaccines. Zika virus, which is a flavivirus primarily transmitted by mosquitoes, can cause devastating congenital syndrome in fetuses of pregnant women, including microcephaly, craniofacial disproportion, spasticity, ocular abnormalities, and miscarriage. In adults, Zika infection has been linked to the autoimmune disorder Guillain-Barr{\'e} syndrome. Thus, despite the current waning in newly reported Zika infections, an efficacious vaccine is urgently needed to help limit the emergence of another detrimental epidemic. Here we summarize the current status of the Zika vaccine pipeline and highlight the challenges for clinical efficacy trials. Shan et al. review the current status of the Zika virus vaccine pipeline, highlight the challenges for efficacy trial in humans, underline the knowledge gaps required for clinical development, and provide potential solutions to overcome the barriers toward licensure.",
author = "Chao Shan and Xuping Xie and Pei-Yong Shi",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.chom.2018.05.021",
language = "English (US)",
journal = "Cell Host and Microbe",
issn = "1931-3128",
publisher = "Cell Press",

}

TY - JOUR

T1 - Zika Virus Vaccine

T2 - Progress and Challenges

AU - Shan, Chao

AU - Xie, Xuping

AU - Shi, Pei-Yong

PY - 2018/1/1

Y1 - 2018/1/1

N2 - The explosive emergence of Zika virus has inspired a global effort to develop vaccines. Zika virus, which is a flavivirus primarily transmitted by mosquitoes, can cause devastating congenital syndrome in fetuses of pregnant women, including microcephaly, craniofacial disproportion, spasticity, ocular abnormalities, and miscarriage. In adults, Zika infection has been linked to the autoimmune disorder Guillain-Barré syndrome. Thus, despite the current waning in newly reported Zika infections, an efficacious vaccine is urgently needed to help limit the emergence of another detrimental epidemic. Here we summarize the current status of the Zika vaccine pipeline and highlight the challenges for clinical efficacy trials. Shan et al. review the current status of the Zika virus vaccine pipeline, highlight the challenges for efficacy trial in humans, underline the knowledge gaps required for clinical development, and provide potential solutions to overcome the barriers toward licensure.

AB - The explosive emergence of Zika virus has inspired a global effort to develop vaccines. Zika virus, which is a flavivirus primarily transmitted by mosquitoes, can cause devastating congenital syndrome in fetuses of pregnant women, including microcephaly, craniofacial disproportion, spasticity, ocular abnormalities, and miscarriage. In adults, Zika infection has been linked to the autoimmune disorder Guillain-Barré syndrome. Thus, despite the current waning in newly reported Zika infections, an efficacious vaccine is urgently needed to help limit the emergence of another detrimental epidemic. Here we summarize the current status of the Zika vaccine pipeline and highlight the challenges for clinical efficacy trials. Shan et al. review the current status of the Zika virus vaccine pipeline, highlight the challenges for efficacy trial in humans, underline the knowledge gaps required for clinical development, and provide potential solutions to overcome the barriers toward licensure.

UR - http://www.scopus.com/inward/record.url?scp=85048570657&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048570657&partnerID=8YFLogxK

U2 - 10.1016/j.chom.2018.05.021

DO - 10.1016/j.chom.2018.05.021

M3 - Article

C2 - 30008291

AN - SCOPUS:85048570657

JO - Cell Host and Microbe

JF - Cell Host and Microbe

SN - 1931-3128

ER -